Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: diabetes

May 27, 2022 Drug delivery / Pharma applications

Insulin Complexation with Cyclodextrins—A Molecular Modeling Approach

Around 5% of the population of the world is affected with the disease called diabetes mellitus. The main medication of

Continue reading

March 16, 2022 Food / Non-pharma applications

Starch-based nanoparticles and cyclodextrin for prebiotics delivery and controlled glucose release in the human gut

In this paper, the preparation and properties of several starch-based nanoparticles (SNPs) and cyclodextrins (CDs) derivatives are reviewed. In particular,

Continue reading

January 20, 2022 Drug delivery / Pharma applications

Insulin Complexation with Cyclodextrins—A Molecular Modeling Approach

The insulin is a peptide hormone, secreted by the pancreas, first discovered in 1922 by Banting and Macleod [5]. This

Continue reading

November 23, 2020 CD derivatives / Drug delivery / Pharma applications

Inclusion complex based on N-acetyl-L-cysteine and arginine modified hydroxypropyl-β-cyclodextrin for oral insulin delivery

Insulin is the most effective drug in the treatment of diabetes mellitus. At present, subcutaneous injection is still the common

Continue reading

Posts pagination

«Previous Posts 1 2

Recent Posts

  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Book chapter: Functionalized cyclodextrins in drug delivery
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (28)
  • Analysis (75)
  • CD as API (361)
  • CD derivatives (443)
  • Cosmetics and toilettry (55)
  • Diagnosis (15)
  • Drug delivery (832)
  • E-ducation (64)
  • Environmental (144)
  • Events (243)
  • Food (239)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (46)
  • Non-pharma applications (428)
  • Other industrial use (114)
  • Pharma applications (1,241)
  • Supramolecular systems (45)
  • Uncategorized (176)

Top Posts

  • Enhancing Linezolid Solubilization with β-Cyclodextrin Polymer Fractions of Different Molecula Weight
  • Rafael Holdings Announced Submission of New Drug Application to FDA for Trappsol®Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C
  • Concluding 22nd International Cyclodextrin Symposium (ICS-22)
  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Disruption of endosomal transport in cyclodextrin-mediated cytotoxicity
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Arthur Lütringhaus, Godfather of catenanes was born 120 years ago
  • 16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
  • β-Cyclodextrin-Complexed 1,8-Cineole Attenuates Motor Deficits and Preserves Tyrosine Hydroxylase Immunoreactivity in a Reserpine-Induced Mouse Model of Parkinsonism
  • Enantioseparation and molecular docking study of selected chiral pharmaceuticals on a commercialized phenylcarbamate-β-cyclodextrin column using polar organic mode

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,470 other subscribers
Loading Comments...